Metabolic dysregulation, including insulin resistance and hyperinsulinemia, creates a pro-tumorigenic environment by increasing free insulin-like growth factor 1 (IGF-1) levels and enhancing hormone availability, which supports hormone-dependent cancers [32,33]. This evidence concerns the gene IGF1 and Hyperinsulinemia.